Protagonist Therapeutics
PTGX
#3747
Rank
ยฃ2.13 B
Marketcap
ยฃ35.78
Share price
-2.90%
Change (1 day)
182.34%
Change (1 year)

Revenue for Protagonist Therapeutics (PTGX)

Revenue in 2024 (TTM): ยฃ0.25 Billion

According to Protagonist Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ0.24 Billion. In 2023 the company made a revenue of ยฃ47.09 Million an increase over the revenue in the year 2022 that were of ยฃ21.97 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Protagonist Therapeutics from 2015 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.25 B435.75%
2023 ยฃ47.09 M114.35%
2022 ยฃ21.97 M8.41%
2021 ยฃ20.26 M-3.5%
2020 ยฃ21 M11822.44%
2019 ยฃ0.17 M-99.28%
2018 ยฃ24.36 M64.11%
2017 ยฃ14.84 M
2016 N/A
2015 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA